Validating Pre-Treatment Body Mass Index as Moderator of Antidepressant Treatment Outcomes: Findings from CO-MED Trial

BACKGROUND: Currently, there are no valid clinical or biological markers to personalize the treatment of depression. Recent evidence suggests that body mass index (BMI) may guide the selection of antidepressant medications with different mechanisms of action. METHODS: Combining Medications to Enhanc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Affect Disord
Main Authors: Jha, Manish K., Wakhlu, Shereen, Dronamraju, Neha, Minhajuddin, Abu, Greer, Tracy, Trivedi, Madhukar H.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312180/
https://ncbi.nlm.nih.gov/pubmed/29522941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2018.02.089
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares